American Association for Cancer Research
00085472can141053-sup-129688_1_supp_2689666_nd0qs4.doc (49 kB)

Supplemental Table 3 from Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression

Download (49 kB)
journal contribution
posted on 2023-03-30, 23:28 authored by Afshin Beheshti, Sébastien Benzekry, J. Tyson McDonald, Lili Ma, Michael Peluso, Philip Hahnfeldt, Lynn Hlatky

Supplemental Table 3. Top 5 IPA canonical pathways for each group



Aging is the major determinant of cancer incidence, which, in turn, is likely dictated in large part by processes that influence the progression of early subclinical (occult) cancers. However, there is little understanding of how aging informs changes in aggregate host signaling that favor cancer progression. In this study, we provide direct evidence that aging can serve as an organizing axis to define cancer progression-modulating processes. As a model system to explore this concept, we employed adolescent (68 days), young adult (143 days), middle-aged (551 days), and old (736 days) C57BL/6 mice as syngeneic hosts for engraftment of Lewis lung cancer to identify signaling and functional processes varying with host age. Older hosts exhibited dysregulated angiogenesis, metabolism, and apoptosis, all of which are associated with cancer progression. TGFβ1, a central player in these systemic processes, was downregulated consistently in older hosts. Our findings directly supported the conclusion of a strong host age dependence in determining the host tumor control dynamic. Furthermore, our results offer initial mechanism-based insights into how aging modulates tumor progression in ways that may be actionable for therapy or prevention. Cancer Res; 75(6); 1134–43. ©2015 AACR.

Usage metrics

    Cancer Research



    Ref. manager